US Primary Care Physicians' Viewpoints on HPV Vaccination for Adults 27 to 45 Years.
US Primary Care Physicians' Viewpoints on HPV Vaccination for Adults 27 to 45 Years.
复制标题
DOI：
10.3122/jabfm.2021.01.200408
复制
发表时间：
2021-01
影响因子：
2.9
通讯作者：
Kempe, Allison
中科院分区：
文献类型：
--
作者：
Hurley, Laura P.;O'Leary, Sean T.;Markowitz, Lauri E.;Crane, Lori A.;Cataldi, Jessica R.;Brtnikova, Michaela;Beaty, Brenda L.;Gorman, Carol;Meites, Elissa;Lindley, Megan C.;Kempe, Allison
关键词：
2019 年 6 月，免疫实践咨询委员会 (ACIP) 建议对 27-45 岁成人的人乳头瘤病毒 (HPV) 疫苗接种进行共同临床决策 (SCDM)。我们的目标是对初级保健医生进行评估：1) 27-45 岁成人 HPV 疫苗接种的最新实践，2) 对 HPV 和新 SCDM 建议的了解，以及 3) 对新 SCDM 建议的态度和预期效果。 2019 年 10 月至 12 月，我们对美国医师学会和美国家庭医师学会的 494 名普通内科医生 (GIM) 和 474 名家庭医生 (FP) 会员分别进行了一项互联网和邮件调查。有效率 64%（617/968，GIM 57%，FP 71%）。 58% 的人了解 ACIP 的新建议； 42% 的人建议 27-45 岁的成年人接种 HPV 疫苗，但大多数人只对极少数患者接种了 HPV 疫苗（73% 为 0 岁，22% 为 1-3 岁）。分别有 55% 和 63% 的人不知道 HPV 疫苗接种不能预防现有 HPV 相关癌症或感染的进展。 57% 的人不确定在 SCDM 讨论 HPV 疫苗接种时应强调什么。大多数人表示，由于新建议的实施，他们更有可能向 27-45 岁的成年人推荐 HPV 疫苗接种。医生有兴趣建议 27 至 45 岁的成年人接种 HPV 疫苗，尽管 ACIP 并不常规建议该年龄范围接种疫苗。大多数人需要更多有关该年龄段 HPV 疫苗最佳使用的教育。
In June 2019, the Advisory Committee on Immunization Practices (ACIP) recommended shared clinical decision-making (SCDM) regarding human papillomavirus (HPV) vaccination for adults 27–45 years. Our objectives were to assess among primary care physicians: 1) recent practice regarding HPV vaccination for adults 27–45 years, 2) knowledge of HPV and the new SCDM recommendation, and 3) attitudes toward and anticipated effect of the new SCDM recommendation. In October to December 2019, we administered an Internet and mail survey to national networks of 494 general internist (GIM) and 474 family physician (FP) members of the American College of Physicians and American Academy of Family Physicians, respectively. Response rate was 64% (617/968, GIM 57%, FP 71%). 58% were aware of the new ACIP recommendation; 42% had recommended HPV vaccination to adults 27–45 years, but most had administered HPV vaccine to very few of these patients (73% to 0 and 22% to 1–3). 55% and 63% were unaware that HPV vaccination does not prevent progression of existing HPV-related cancers or infections, respectively. 57% were not sure what to emphasize when having a SCDM conversation about HPV vaccination. A majority reported they will be more likely recommend HPV vaccination to adults in the 27–45 years age range as a result of the new recommendation. Physicians are interested in recommending HPV vaccination for adults age 27–45 years despite ACIP not routinely recommending it in this age range. The majority need more education about the optimal use of HPV vaccine in this age group.
登录
查看更多内容
影响因子：
5.5
作者：
Lin, Yulan;Lin, Zheng;Wong, Li Ping
通讯作者：
Wong, Li Ping
影响因子：
5.7
作者：
Abbo, Elmer D.;Zhang, Qi;Huang, Elbert S.
通讯作者：
Huang, Elbert S.
影响因子：
2.9
作者：
Crane, Lori A.;Daley, Matthew F.;Stokley, Shannon
通讯作者：
Stokley, Shannon
影响因子：
39.2
作者：
Laprise, Jean-Francois;Chesson, Harrell W.;Brisson, Marc
通讯作者：
Brisson, Marc
影响因子：
158.5
作者：
Garland, Suzanne M.;Hernandez-Avila, Mauricio;Koutsky, Laura A.
通讯作者：
Koutsky, Laura A.